Why the study?
Does QT interval prolongation predict increased mortality in type 1 diabetic patients?
Population
316 type 1 diabetic patients evaluated for diabetic neuropathy and QT interval prolongation
Comparison
Prolonged QTc interval (exposure) vs Normal QTc interval
Design
Cohort
Follow-up
5 years
Authors
Loading...
QTc monitoring may aid risk stratification in type 1 diabetes; leaves open causality and need for prospective validation.
Does QT interval prolongation predict increased mortality in type 1 diabetic patients?
QTc prolongation is a strong, independent predictor of 5-year mortality in patients with type 1 diabetes.
Veglio et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: